A rare type of appendix cancer, called appendiceal adenocarcinoma, is increasingly appearing in the United States. The ...

Appendix cancer cases are rising among millennials and Gen X, often mimicking diverticulitis symptoms. Early diagnosis ...

Researchers are reporting a startling spike in appendiceal adenocarcinoma (AA) — otherwise known as appendix cancer — in ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

Rates of appendiceal adenocarcinoma more than tripled among Americans born in 1980 compared with those born in 1945, a study ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.

The FDA has granted fast track designation to nadunolimab for use in combination with gemcitabine and nab-paclitaxel to treat patients with previously untreated, metastatic PDAC with high IL1RAP ...

A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

Combining TTFields with gemcitabine and nab-paclitaxel can improve OS in patients with locally advanced pancreatic adenocarcinoma, results of the PANOVA-3 trial suggest.